— Compassionate use results to be presented at UMDF’s Mitochondrial Medicine 2019 symposium — — Minovia initiates U.S. operations in Cambridge, Mass. — — John Cox named Executive Chairman — Minovia Therapeutics today announced...
Gemcabene safely lowered serum triglycerides (TGs), the primary endpoint, in a subset of FPLD patients Gemphire Therapeutics Inc. (NASDAQ: GEMP) today announced top-line results based upon the Company’s preliminary review of the limited top-line dataset from the...
Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced that it has received clearance from the...
Global pharmaceutical company expands use of Medidata Rave Clinical Cloud™ to spur growth and innovation Agreement builds on long-standing relationship since 2006 Unified platform approach creates a single source of truth for greater efficiency and accelerated trials...
INNATE PHARMA ANNOUNCES PUBLICATION OF IPH4102 PHASE I CLINICAL TRIAL RESULTS FOR CTCL IN THE LANCET ONCOLOGY ·Data to date demonstrate high activity and favorable safety profile in Sézary syndrome, an aggressive form of cutaneous T-cell lymphoma (CTCL)...
Email
Text